Physician profile
John A Jackalone
NPI 1174620983
$65,571.52
in general payments reported to CMS, 2019-2025
30 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,967 · 2020: $468 · 2021: $656 · 2022: $60K · 2023: $1,068 · 2024: $1,242 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolab Sciences, INC. | $58,400.00 | 2022 | |
| Organogenesis INC. | $2,305.62 | 2019-2025 | Puraply, Via Matrix, Apligraf |
| Smith+Nephew, INC. | $1,270.24 | 2019-2025 | Collagenase Santyl, Oasis, Grafix |
| Medical Device Business Services, INC. | $918.48 | 2019 | |
| Abbvie INC. | $632.82 | 2022-2025 | |
| Nevro Corp. | $192.59 | 2022-2023 | Senza |
| Misonix INC | $180.08 | 2019-2020 | |
| Mimedx Group, INC. | $179.79 | 2024-2025 | |
| Averitas Pharma INC. | $148.85 | 2023 | Qutenza |
| Treace Medical Concepts, INC. | $145.94 | 2024 | |
| Paratek Pharmaceuticals, INC. | $145.41 | 2022-2023 | Nuzyra |
| Lifenet Health | $141.99 | 2024 | Theragenesis Wound Matrix |
| Biocomposites INC | $138.41 | 2024 | |
| Kci USA, INC. | $125.00 | 2019 | |
| Melinta Therapeutics, LLC | $124.59 | 2023 | Kimyrsa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $99.74 | 2023 | Hydrofera Blue, Cutimed Sorbact |
| Convatec INC. | $87.70 | 2019-2021 | |
| Integra Lifesciences Corporation | $40.36 | 2019-2021 | |
| Acera Surgical, INC. | $39.54 | 2024 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $36.54 | 2020-2024 | |
| Kerecis Limited | $31.34 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $31.05 | 2025 | Physio-Stim |
| Advanced Oxygen Therapy INC. | $28.40 | 2025 | Topical Oxygen Chamber For Extremities |
| Imbed Biosciences INC. | $21.06 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $19.70 | 2024 | Caldolor |
| Tei Medical INC. | $18.42 | 2019 | |
| Wright Medical Technology, INC. | $17.52 | 2019 | |
| Bioventus LLC | $17.32 | 2021 | |
| Allergan, INC. | $16.57 | 2020 | |
| Horizon Therapeutics Plc | $16.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jackalone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.